3Daughters Announces NIH to Support Testing of Novel Frameless Magnetic Copper IUD (3D-001) for Contraception
September 25, 2024 08:00 ET
|
3Daughters
MANSFIELD, Mass., Sept. 25, 2024 (GLOBE NEWSWIRE) -- 3Daughters, Inc., a clinical development company fueling evolutionary healthcare for women, announced the Eunice Kennedy Shriver National...
AITX Secures $2 Million Commitment in Non-Dilutive Funding
December 04, 2023 08:40 ET
|
Artificial Intelligence Technology Solutions, Inc.
Detroit, Michigan, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Artificial Intelligence Technology Solutions, Inc. (OTCPK:AITX), a global leader in AI-driven security and productivity solutions, proudly...
Neuronascent Announces NIA Grant Award for NNI-362 to Reach Phase 2 Clinical Trials for Mild to Moderate Alzheimer’s Disease
August 22, 2023 06:00 ET
|
Neuronascent, Inc.
ROCKVILLE, Md., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Neuronascent Inc., a privately-held neuron regeneration therapeutics company, today announced that the National Institute of Aging (NIA), has...
Nemaura Medical Secures $6.5m in Non-Dilutive Funding
August 11, 2023 16:05 ET
|
Nemaura Medical, Inc
Loughborough, England, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on commercializing a daily disposable wearable glucose sensor and...
Nemaura Medical Strengthens Balance Sheet with Further Non-Dilutive Funding
May 23, 2022 06:30 ET
|
Nemaura Medical, Inc
Loughborough, England, May 23, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on commercializing a daily disposable wearable glucose sensor and...
Arch Biopartners Receives Government of Canada Funding to Support Phase II Therapeutic Trial of Metablok for COVID-19
December 15, 2020 12:52 ET
|
Arch Biopartners
Government of Canada contribution up to $6.7 MillionFunding from the department of Innovation, Science and Economic Development through the Strategic Innovation Fund and part of the Government of...
Celsion Strengthens Its 2019 Balance Sheet with the Approval of Its Application to Sell Net Operating Losses for $2.1 Million in Non-Dilutive Funding
October 01, 2019 08:00 ET
|
Celsion CORP
$2 Million in Additional NOL Sales are Available to the Company in 2020 Funding Through the New Jersey Technology Business Tax Certificate Transfer (NOL) Program LAWRENCEVILLE, N.J., Oct. 01,...
Patriot One enters into conditional agreement in principle for technology funding with International Defence Contractor
August 14, 2018 08:30 ET
|
Patriot One Technologies Inc
TORONTO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Patriot One Technologies Inc. (TSX.V: PAT) (OTCQX: PTOTF) (FRANKFURT: 0PL) (“Patriot One” or the “Company”), makers of the award-winning PATSCAN CMR covert...